Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Gains from Investment Securities (2016 - 2025)

Apyx Medical filings provide 12 years of Gains from Investment Securities readings, the most recent being -$99000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 55.8% to -$99000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$292000.0, a 10.19% decrease, with the full-year FY2025 number at $1.6 million, up 3.4% from a year prior.
  • Gains from Investment Securities hit -$99000.0 in Q4 2025 for Apyx Medical, down from $1.1 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $8.6 million in Q2 2025 to a low of -$2.4 million in Q3 2023.
  • Median Gains from Investment Securities over the past 4 years was -$9500.0 (2022), compared with a mean of $1.1 million.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 8282.76% in 2023 and later skyrocketed 28503.66% in 2025.
  • Apyx Medical's Gains from Investment Securities stood at $1000.0 in 2022, then plummeted by 5200.0% to -$51000.0 in 2023, then tumbled by 339.22% to -$224000.0 in 2024, then skyrocketed by 55.8% to -$99000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were -$99000.0 (Q4 2025), $1.1 million (Q3 2025), and $8.6 million (Q2 2025) per Business Quant data.